Skip to main content
F1000Research logoLink to F1000Research
. 2025 Apr 9;12:566. Originally published 2023 May 30. [Version 3] doi: 10.12688/f1000research.130430.3

Cigarette smoke alters circRNA expression in human T-cells

So Jin Hong 1, Zhaohao Liao 2, Kenneth W Witwer 2,3,4, Ashley E Russell 2,5,a
PMCID: PMC11831728  PMID: 39963375

Version Changes

Revised. Amendments from Version 2

The Introduction section of our manuscript has been expanded to provide further explanation and clarification regarding the rationale behind the objectives of our experiment, as well as the potential contributions of the data to future research.

Abstract

Circular RNAs (circRNAs), once thought to be a result of splicing errors, have been found to be involved in various molecular processes and the pathology of various diseases, including cancer and neurodegenerative diseases. Additionally, circRNA expression was found to be altered by lifestyle habits, such as smoking cigarettes. Past studies have revealed that the rate of smoking remains high in people living with human immunodeficiency virus (HIV). In this study, we isolated total RNA from uninfected T-cells that have been exposed to cigarette smoke and compared the expression levels of circRNAs to those of T-cells that were not exposed to cigarette smoke. We identified certain circRNAs that were upregulated or downregulated in T-cells when exposed to cigarette smoke. These data indicate that the study of circRNAs is warranted within the context of HIV.

Keywords: Cigarette smoke, T-cells, circRNA, HIV

Introduction

Circular RNAs (circRNAs) are endogenous non-coding RNAs covalently bonded circular structures that are created through back-splicing events ( Yu & Kuo, 2019). CircRNAs are predominantly present in the cytoplasm, but have also been shown to be present in extracellular vesicles (EVs) released from cells ( Gotts et al., 2018; Preußer et al., 2018). Although first thought to be a result of splicing errors, circRNAs have been found to play important roles in various molecular processes, such as functioning as microRNA (miRNA) sponges ( Hansen et al., 2013). miRNAs are small non-coding RNAs that are involved in regulating protein production by binding to complementary sequences in the 3′ untranslated region of messenger RNAs (mRNAs) and preventing their translation into protein ( Jonas & Izaurralde, 2015). By binding miRNAs, circRNAs can alleviate repression of linear mRNA targets and thus influence gene regulation.

In some cancers, including pancreatic and breast cancer, aberrant expression of circRNAs has been observed ( Rong et al., 2021; Wang et al., 2019a, 2019b). Altered expression of circRNAs has also been associated with neurodegenerative diseases such as Alzheimer’s Disease ( Lo et al., 2020). Together, these data suggest that circRNAs are involved in disease pathology and may serve as novel biomarkers for various diseases. Notably, lifestyle habits like cigarette smoking alter circRNA expression as well ( Zeng et al., 2019), indicating that a person’s smoking status may impact epigenetic mechanisms mediated by miRNAs.

Although the rate of smoking in the general population has been on the decline, it remains higher in people living with human immunodeficiency virus (HIV) ( Socio et al., 2020). The persistently high rate of smoking in people living with HIV has been found to be due to complex psychosocial characteristics and unhealthy behavioral factors including lower education and economic level, unemployment, depression, and drug usage ( Yang et al., 2022). Individuals living with HIV who smoke tend to have a more serious prognosis or develop other HIV-related diseases such as cancers, pneumonia, and chronic obstructive pulmonary disease (COPD) ( Giles et al., 2018; Hile et al., 2016), the pathophysiology of which may be impacted by epigenetic regulation of miRNAs and circRNAs. A significant amount of research over the years has found that HIV primarily infects T-cells and result in depletion of T-cells population through various mechanisms, including direct virus attack leading to cytolytic effect and chronic immune activation resulting in apoptosis ( Vijayan et al., 2017). In the current study, we sought to investigate the effects of cigarette smoke on circRNA expression profiles in a model of uninfected human T-cells (H9 cells) to understand how cigarette smoke impacts circRNA expression in this cell type, a common target of HIV ( Walker & McMichael, 2012). These data will provide a foundation for investigating circRNA expression in HIV-infected H9 cells that have been exposed to cigarette smoke to understand how these two variables intersect. Experiments conducted in China found a strong correlation between smoking and expression levels of unique circRNAs (hsa_circ_0049875 and hsa_circ_0042590) in COPD peripheral blood mononuclear cells (PBMCs), and the frequency of acute exacerbations was shown to be substantially linked with these circRNA expressions ( Shen et al., 2024). These recent findings emphasize the importance of identifying circRNAs that could potentially serve as biomarkers of diseases affecting immune cells, like HIV, in the setting of cigarette smoke exposure. The data published in the manuscript could be utilized as a foundation for further exploration of circRNAs affected by cigarette smoke in HIV infected T-cells.

Methods

Preparation of 100% cigarette smoke extract media (CSEM)

Cigarette smoke extract (CSE) was made using an apparatus and techniques as previously described by our lab ( Bernstein et al., 2019). Briefly, 25 mL of R10 media, supplemented with 10% fetal bovine serum, 1 mM L-glutamine (Thermo Fisher, MA, USA; Cat #25030081), 1 mg/mL Pen-Strep (Thermo Fisher, MA, USA; Cat #15140148), and 10 mM HEPES (Thermo Fisher, MA, USA; CAT #15630080), was aliquoted into a 50 mL conical tube and sealed with parafilm. A 5 mL serological pipette, cut at the 3.5 mL mark, was inserted through the parafilm seal. This apparatus was connected to one end of a Tygon tubing (Cole-Parmer, Cat. No. 06509-17), which was inserted into a Cole-Parmer Masterflex L/S peristaltic pump at speed setting of 32. A 1 mL pipette tip was tightly inserted into the other end of the Tygon tubing. Next, one Spectrum research-grade cigarette ( Richter et al., 2016) (filter intact) obtained through the National Institute of Drug Abuse was lit with a Bunsen burner and tightly inserted into the wide end of the 1 mL pipette tip. The cigarette was then smoked continuously by the peristaltic pump into the cell culture medium. The resulting product was considered 100% CSE. CSE media was created using the same paradigm each time, using Spectrum cigarettes that are tightly regulated by the FDA, and following the general techniques utilized by other similar studies ( Comer et al., 2014; Hernandez et al., 2013; Ji et al., 2017; Kim et al., 2010).

H9 cell cigarette smoke exposure

H9 cells (passage 1-6) were used for all experiments, as these cells are commonly used for cancer and immunology research. Approximately 400,000 cells/mL of H9 cells were passaged into six T75 flasks and were exposed to either 0% or 50% CSEM. After 24 hours, the percentage of viable cells was measured ( Table 1) using a Muse cell counter and Muse Count & Viability Reagent (Luminex, Cat. No. MCH600103). H9 cells were used for this experiment specifically for their susceptibility to HIV-1 infections. Future experiments would be replicated with HIV-infected H9 cells so we can differentiate the effects of cigarette smoke extract on the control versus the HIV-infected cells.

Table 1. Percentage of viable H9 cells.

Percentages of cell viability and density were measured and calculated after 24 hours for six flasks of H9 cells: three with 0% CSEM for 24 hours and three with 50% CSEM. CSEM, cigarette smoke extract media.

% CSEM Viable cells/mL % Viability
0% - flask #1 1,195,679 98.1
0% - flask #2 1,196,918 97.1
0% - flask #3 1,248,749 96.7
50% - flask #1 723,372.7 85.9
50% - flask #2 632,603.8 86.1
50% - flask #3 715,714.1 87.9

Total RNA and circRNA isolation

The Invitrogen mirVana™ miRNA Isolation Kit (ThermoFisher Scientific, Cat. No. AM1560) was used as directed to isolate total cellular RNA. Approximately 10 5 cells from each flask were lysed with 600 μL lysis buffer. Then, 750 μL 100% ethanol was added and centrifuged at 10,000 × g for 15 seconds. The filters containing RNA were washed, and total RNA was eluted with 100 μL pre-heated nuclease-free water, centrifuging at maximum speed for 25 seconds. RNA quality was checked using an Agilent Fragment Analyzer. Next, 5,000 ng of RNA from each sample was shipped to Arraystar for hybridization with the Human Circular RNA Array (Cat. No. AS-S-CR-H-V2.0).

Human circRNA array, data processing, and analysis

Total RNAs from each sample were quantified using the NanoDrop ND-1000 and the integrity of the samples were evaluated through electrophoresis on a denaturing agarose gel. Total RNAs were then digested with RNase R (Epicentre, Inc.) to degrade linear RNAs and enrich circRNAs. A random priming method was used to amplify and transcribe the enriched circRNAs into fluorescent complementary RNAs (cRNAs) (Arraystar Super RNA Labeling Kit; Arraystar), which were then purified by RNeasy Mini Kit (Qiagen). Nanodrop ND-1000 was used to measure the concentration and specific activity of the labeled cRNAs (pmol Cy3/μg cRNA). A total of 1 μg of each labeled cRNA was fragmented by adding 5 μl of 10× Blocking Agent and 1 μl of 25× Fragmentation Buffer. The mixture was then incubated at 60°C for 30 minutes, then 2× Hybridization buffer was added to dilute the labeled cRNA. Then, 50 μl of the hybridization solution was dispensed into the gasket slide and assembled to the circRNA expression microarray slides, which were washed, fixed, and scanned with the Agilent Scanner G2505C.

Agilent Feature Extraction Software (version 11.0.1.1) (RRID:SCR_014963) was used to extract raw data from the scanned images. Quantile normalization of the raw data and subsequent data processing were conducted using the R software Limma package (RRID:SCR_010943). Low intensity filtering was then performed to retain circRNAs that at least one out of six samples were flagged as “present” or “marginal”. The quality control flags of “present”, “marginal”, or “absent” were determined based on various features, including positive and significant signal, saturation, population outlier, above background, and uniformity of the background. The fold change between the cigarette exposed samples and control samples were calculated and the statistical significance of the difference was estimated using an unpaired t-test. circRNAs having fold changes greater than or equal to 1.5 and p-values less than or equal to 0.05 were selected as significantly differentially expressed, using Microsoft Excel (RRID:SCR_016137). The false detection rate for each differentially expressed circRNAs were calculated using Benjamini-Hochberg procedure. These data, while suggestive, do not support robust statistical analysis secondary to the number of repeats and the large number of RNAs.

Dataset

The Human Circular RNA Array revealed 234 circRNAs that were 1.5-fold upregulated (Up Regulated circRNAs) and 42 circRNAs that were 1.5-fold downregulated (Down Regulated circRNAs) in H9 cells cultured in 50% CSEM relative to H9 cells grown in 0% CSEM ( Hong et al., 2023).

Funding Statement

This project was supported in part by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) through grants DA047807 and DA040385 (to KWW).

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[version 3; peer review: 1 approved

Data availability

Underlying data

Gene Expression Omnibus: Cigarette Smoke Alters CircRNA Expression in Human T-Cells. GSE228979; https://identifiers.org/geo/GSE228979 ( Hong et al., 2023).

This series contains the following underlying data:

  • -

    Datasheet 1 (1.5 Fold Up Regulated circRNAs. Datasheet 1 contains raw and normalized fluorescence intensities from the ArrayStar circRNA Microarray, for 234 circRNAs that were significantly upregulated in H9 cells after cigarette smoke exposure. The circRNA ID was obtained by inputting the transcript and sequence information into circBase or other literatures).

  • -

    Datasheet 2 (1.5 Fold Down Regulated CircRNAs. Datasheet 2 contains raw and normalized fluorescence intensities from the ArrayStar circRNA Microarray, for 42 circRNAs that were significantly downregulated in H9 cells after cigarette smoke exposure. The circRNA ID was obtained by inputting the transcript and sequence information into circBase or PMIDs).

References

  1. Bernstein ED, Liao Z, Witwer KW: Cytotoxicity of aqueous cigarette smoke extract is affected by properties of pipettes used to prepare the extract. Matters. 2019;2019. [PMC free article] [PubMed] [Google Scholar]
  2. Comer DM, Elborn JS, Ennis M: Inflammatory and cytotoxic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells. BMC Pulm. Med. 2014;14(1):32. 10.1186/1471-2466-14-32 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Giles ML, Gartner C, Boyd MA: Smoking and HIV: what are the risks and what harm reduction strategies do we have at our disposal? AIDS Res. Ther. 2018;15(1):25–26. 10.1186/S12981-018-0213-Z [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gotts JE, Chun L, Abbott J, et al. : Cigarette smoke exposure worsens acute lung injury in antibiotic-treated bacterial pneumonia in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2018;315(1):L25–L40. 10.1152/ajplung.00405.2017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hansen TB, Jensen TI, Clausen BH, et al. : Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. 10.1038/nature11993 [DOI] [PubMed] [Google Scholar]
  6. Hernandez CP, Morrow K, Velasco C, et al. : Effects of cigarette smoke extract on primary activated T cells. Cell. Immunol. 2013;282(1):38. 10.1016/J.CELLIMM.2013.04.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hile SJ, Feldman MB, Alexy ER, et al. : Recent Tobacco Smoking is Associated with Poor HIV Medical Outcomes Among HIV-Infected Individuals in New York. AIDS Behav. 2016;20(8):1722–1729. 10.1007/s10461-015-1273-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hong SJ, Russell AE, Witwer KW, et al. : Cigarette Smoke Alters CircRNA Expression in Human T-Cells.[Dataset]. Gene Expression Omnibus. 2023. Reference Source [DOI] [PMC free article] [PubMed]
  9. Ji M, Zhang Y, Li N, et al. : Nicotine Component of Cigarette Smoke Extract (CSE) Decreases the Cytotoxicity of CSE in BEAS-2B Cells Stably Expressing Human Cytochrome P450 2A13. Int. J. Environ. Res. Public Health. 2017;14(10). 10.3390/IJERPH14101221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jonas S, Izaurralde E: Towards a molecular understanding of microRNA-mediated gene silencing. Nat. Rev. Genet. 2015, July 19;16:421–433. Nature Publishing Group. 10.1038/nrg3965 [DOI] [PubMed] [Google Scholar]
  11. Kim MS, Huang Y, Lee J, et al. : Cellular transformation by cigarette smoke extract involves alteration of glycolysis and mitochondrial function in esophageal epithelial cells. Int. J. Cancer. 2010;127(2):269. 10.1002/IJC.25057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lo I, Hill J, Vilhjálmsson BJ, et al. : Linking the association between circRNAs and Alzheimer’s disease progression by multi-tissue circular RNA characterization. RNA Biol. 2020;17:1789–1797. 10.1080/15476286.2020.1783487 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Preußer C, Hung LH, Schneider T, et al. : Selective release of circRNAs in platelet-derived extracellular vesicles. J. Extracell. Vesicles. 2018;7(1). 10.1080/20013078.2018.1424473 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Richter P, Steven PR, Bravo R, et al. : Characterization of SPECTRUM Variable Nicotine Research Cigarettes. Tob. Regul. Sci. 2016;2(2):94–105. 10.18001/TRS.2.2.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rong Z, Xu J, Shi S, et al. : Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment. Theranostics. 2021;11(6):2755–2769. Ivyspring International Publisher. 10.7150/THNO.56174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shen XR, Liu YY, Qian RQ, et al. : Circular RNA Expression of peripheral blood mononuclear cells associated with risk of acute exacerbation in smoking chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 2024;19:789. 10.2147/COPD.S448759 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Socio GV, Pasqualini M, Ricci E, et al. : Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study. BMC Public Health. 2020;20(1):710–734. 10.1186/S12889-020-08862-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Vijayan KV, Karthigeyan KP, Tripathi SP, et al. : Pathophysiology of CD4+ T-Cell Depletion in HIV-1 and HIV-2 Infections. Front. Immunol. 2017;8(MAY):580. 10.3389/FIMMU.2017.00580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Walker B, McMichael A: The T-Cell Response to HIV. Cold Spring Harb. Perspect. Med. 2012;2(11). 10.1101/CSHPERSPECT.A007054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wang J, Zhu M, Pan J, et al. : Circular RNAs: A rising star in respiratory diseases. Respir. Res. 2019a;20(1). BioMed Central Ltd. 10.1186/s12931-018-0962-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wang J, Zhang Q, Zhou S, et al. : Circular RNA expression in exosomes derived from breast cancer cells and patients. Epigenomics. 2019b;11(4):411–421. 10.2217/epi-2018-0111 [DOI] [PubMed] [Google Scholar]
  22. Yang J, Lin JL, Liu J, et al. : Estimates of prevalence, time-trend, and association of smoking in adults living with HIV, HBV, and HCV (NHANES 1999–2018). Sci. Rep. 2022;12(1):1–9. 10.1038/s41598-022-24291-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Yu CY, Kuo HC: The emerging roles and functions of circular RNAs and their generation. J. Biomed. Sci. 2019;26(1):12–29. BioMed Central Ltd. 10.1186/s12929-019-0523-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zeng N, Wang T, Chen M, et al. : Cigarette smoke extract alters genome-wide profiles of circular RNAs and mRNAs in primary human small airway epithelial cells. J. Cell. Mol. Med. 2019;23(8):5532–5541. 10.1111/jcmm.14436 [DOI] [PMC free article] [PubMed] [Google Scholar]
F1000Res. 2025 Feb 13. doi: 10.5256/f1000research.167219.r359113

Reviewer response for version 2

Meity Ardiana 1

You provided a clear and well-researched background on circRNAs, their formation, and their functional significance. The explanation of circRNAs as miRNA sponges is well-supported with references, also, the introduction connects circRNAs to major diseases like cancer and neurodegenerative disorders which increases the study's significance and valuable. However, there are some suggestions that I think you could consider adding. The connection between smoking, HIV, and disease progression is mentioned, but explaining why Tcells are the main focus would make the rationale stronger.

Consider briefly explaining:

˗ Why H9 cells specifically (e.g., their relevance as a model for HIV studies)?

˗ If circRNA research in HIV-T cells is novel, highlight this gap The discussion on HIV-related diseases could be slightly expanded.

For instance: ˗

What is the known impact of smoking on immune cells in the context of HIV?

˗ Are there any prior studies linking smoking to circRNA expression in immune cells?

You mentioned that smoking rates are higher among people with HIV, but it would help to briefly explain why. Is it due to behavioral, socioeconomic, or biological factors? Regarding the study's aim, if the ultimate goal is to study HIV-infected cells, briefly mention how these findings might help in future experiments. You've already mentioned that you're trying to understand how the variables intersect, which is a good purpose base, but in what way do you hope that this data help other researchers (probably for those who are studying similar case)?

Are sufficient details of methods and materials provided to allow replication by others?

Partly

Is the rationale for creating the dataset(s) clearly described?

Yes

Are the datasets clearly presented in a useable and accessible format?

Yes

Are the protocols appropriate and is the work technically sound?

Partly

Reviewer Expertise:

I am quite knowledgeable in stem cell

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

F1000Res. 2025 Apr 1.
So Jin Hong 1

Dear Dr. Meity Ardiana,

Thank you for giving us the opportunity to submit a second revised draft of our manuscript. We truly appreciate the time and effort that you have dedicated to providing your valuable feedback. We are grateful for your insightful comments on our paper. We have been able to incorporate changes to reflect most of the suggestions provided. We have highlighted the changes within the manuscript.

Here is a point-by-point response to your comments and concerns.

Comment 1: Why H9 cells specifically (e.g. their relevance as a model for HIV studies)?

Response: This is a great point. We have included in the Methods section “H9 cell cigarette smoke exposure” our rationale for using H9 cells: “H9 cells were used for this experiment specifically for their susceptibility to HIV-1 infections”. These cells are often utilized in immunology research and were used for this experiment specifically for their susceptibility to HIV-1 infections. 

Comment 2: If circRNA research in HIV-T cells is novel, highlight this gap. The discussion on HIV-related diseases could be slightly expanded. For instance: What is the known impact of smoking on immune cells in the context of HIV? Are there any prior studies linking smoking to circRNA expression in immune cells?

Response: Thank you for pointing this out. At the time our experiments were conducted, the relationship between cigarette smoke and circRNA expression was not well known. Since writing of this manuscript, a manuscript written by Shen et al., titled Circular RNA Expression of Peripheral Blood Mononuclear Cells Associated with Risk of Acute Exacerbation in Smoking Chronic Obstructive Pulmonary Disease found a strong correlation between smoking and expression levels of unique circRNAs (hsa_circ_0049875 and hsa_circ_0042590) in COPD peripheral blood mononuclear cells, and the frequency of acute exacerbations was shown to be substantially linked with these circRNA expressions. These recent findings further emphasize the importance of circRNA research in the setting of cigarette smoke exposure and diseases affecting immune cells, such as HIV. This information was added towards the end of the Introduction section.

Comment 3: You mentioned that smoking rates are higher among people with HIV, but it would help to briefly explain why. Is it due to behavioral, socioeconomic, or biological factors? 

Response: We agree with your suggestion. Upon looking into the literature, the persistently high rate of smoking in people living with HIV has been found to be due to combinations of complex psychosocial characteristics and unhealthy behavioral factors, including but not limited to: lower education and economic levels, unemployment, depression, and drug usage. Information has been added to the third paragraph of the Introduction section. 

Comment 4: Regarding the study’s aim, if the ultimate goal is to study HIV-infected cells, briefly mention how these findings might help in future experiments. You’ve already mentioned that you’re trying to understand how the variables intersect, which is a good purpose base, but in what way do you hope that this data help other researchers (probably for those who are studying similar case)?

Response: Thank you for pointing this out. We believe the data published in the manuscript could be utilized as a foundation for further exploration of circRNAs affected by cigarette smoke in HIV infected T-cells. This information has been added at the end of the third paragraph of the Introduction section.

We look forward to hearing from you regarding our edits and to respond to any further questions and comments you may have. 

Sincerely,

So Jin (Diane) Hong

F1000Res. 2024 Jul 29. doi: 10.5256/f1000research.167219.r291433

Reviewer response for version 2

Zahraa Rahal 1

No additional comments.

Are sufficient details of methods and materials provided to allow replication by others?

Partly

Is the rationale for creating the dataset(s) clearly described?

Partly

Are the datasets clearly presented in a useable and accessible format?

Yes

Are the protocols appropriate and is the work technically sound?

Partly

Reviewer Expertise:

I study smoking-induced (cigarette and waterpipe) lung cancer.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

F1000Res. 2024 Apr 1. doi: 10.5256/f1000research.143189.r255365

Reviewer response for version 1

Zahraa Rahal 1

The article investigates the impact of cigarette smoke on circRNA expression in uninfected human T-cells (H9 cells), motivated by the high rate of smoking in people living with human immunodeficiency virus (HIV). It explores circRNAs' role in molecular processes and their potential alteration due to lifestyle habits, like smoking, which may affect the pathology of various diseases. The study employed cigarette smoke extract media to expose H9 cells to cigarette smoke and analyzed changes in circRNA expression using RNA isolation, circRNA enrichment, and microarray analysis.

While the connection between circRNA expression and lifestyle factors like smoking is intriguing, the rationale for focusing specifically on uninfected T-cells and its direct relevance to HIV-positive individuals remains underexplained. The leap from smoking's impact on circRNA in a general context to its implications for HIV-specific pathology could be more robustly justified with existing literature or preliminary data. To strengthen the rationale, the authors should provide a more detailed synthesis of existing literature or preliminary data that directly connects circRNA alterations due to smoking with HIV pathology. Additionally, clarifying why uninfected T-cells serve as an appropriate model for this investigation would help solidify the study's foundation.

The methods are detailed, but there's a lack of information regarding the validation of the experimental setup. For example, the efficiency and reproducibility of the cigarette smoke extraction method and its physiological relevance to real-world smoking exposure might raise questions. It might be useful to include a validation section for the CSE method, comparing it to physiological conditions or other established methods.

Are sufficient details of methods and materials provided to allow replication by others?

Partly

Is the rationale for creating the dataset(s) clearly described?

Partly

Are the datasets clearly presented in a useable and accessible format?

Yes

Are the protocols appropriate and is the work technically sound?

Partly

Reviewer Expertise:

I study smoking-induced (cigarette and waterpipe) lung cancer.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

F1000Res. 2024 May 28.
So Jin Hong 1

Dear Dr. Zahraa Rahal,

Thank you for giving us the opportunity to submit a revised draft of our manuscript. We appreciate the time and effort that you have dedicated to providing your valuable feedback. We are grateful for your insightful comments on our paper. We have been able to incorporate changes to reflect most of the suggestions provided. We have highlighted the changes within the manuscript.

Here is a point-by-point response to your comments and concerns.

  • Comment 1: While the connection between circRNA expression and lifestyle factors like smoking is intriguing, the rationale for focusing specifically on uninfected T-cells and its direct relevance to HIV-positive individuals remains underexplained. The leap from smoking's impact on circRNA in a general context to its implications for HIV-specific pathology could be more robustly justified with existing literature or preliminary data. To strengthen the rationale, the authors should provide a more detailed synthesis of existing literature or preliminary data that directly connects circRNA alterations due to smoking with HIV pathology. Additionally, clarifying why uninfected T-cells serve as an appropriate model for this investigation would help solidify the study's foundation.

    Response: Thank you for pointing this out. T-cells served as an appropriate model for this study, given their susceptibility to HIV infections. Our study using the uninfected T-cells would serve as a baseline for what happens in these cells when exposed to cigarette smoke. The next step of this experiment would be to replicate the study with HIV infected T-cells to study the effects of cigarette smoke in these cells. This information was added to the introduction and the “H9 cell cigarette smoke exposure” methods section.

  • Comment 2: The methods are detailed, but there's a lack of information regarding the validation of the experimental setup. For example, the efficiency and reproducibility of the cigarette smoke extraction method and its physiological relevance to real-world smoking exposure might raise questions. It might be useful to include a validation section for the CSE method, comparing it to physiological conditions or other established methods.

    Response: We agree with your suggestion. However, it is difficult to validate the composition of the CSE, therefore we have followed the exact same paradigm across all experiments and our methodology aligns very closely with other published studies in the field. References have been added to our manuscript.

We look forward to hearing from you regarding our edits and to respond to any further questions and comments you may have.

Sincerely,

So Jin Hong

F1000Res. 2023 Sep 18. doi: 10.5256/f1000research.143189.r197877

Reviewer response for version 1

Thivanka Muthumalage 1

The authors have attempted to show the involvement of circRNA upon exposure to cigarette smoke in HIV infection. While this is important to study, the experimental design lacks information to reproduce the data:

  • Cigarette smoke extracts need meticulous standardization as they quickly change their chemical composition. The authors need to elaborate, and specify the brand of the cigarette and how the extract was standardized each time during preparation. 

  • Cell culture treatments need more details, such as if they were serum-deprived (if not, what is the serum concentration?) and what passage was used. Please explain the rationale for using a cancer cell line. 

  • Please explain the key altered circRNAs and how they are relevant in HIV progression. 

  • There are no results and discussion sections; the implications are hard to find.

Overall, while the circRNA alterations may be useful, the authors have not provided sufficient data or discussion for any translational implications. Major revisions are required before indexing.

Are sufficient details of methods and materials provided to allow replication by others?

No

Is the rationale for creating the dataset(s) clearly described?

Partly

Are the datasets clearly presented in a useable and accessible format?

Partly

Are the protocols appropriate and is the work technically sound?

Partly

Reviewer Expertise:

Inhalation toxicology and lung biology

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

F1000Res. 2024 May 28.
So Jin Hong 1

Dear Dr. Thivanka Muthumalage,

Thank you for giving us the opportunity to submit a revised draft of our manuscript. We appreciate the time and effort that you have dedicated to providing your valuable feedback. We are grateful for your insightful comments on our paper. We have been able to incorporate changes to reflect most of the suggestions provided. We have highlighted the changes within the manuscript.

Here is a point-by-point response to your comments and concerns.

  • Comment 1: Cigarette smoke extracts need meticulous standardization as they quickly change their chemical composition. The authors need to elaborate, and specify the brand of the cigarette and how the extract was standardized each time during preparation.

Response: Thank you for pointing this out. Spectrum research grade cigarettes that are tightly regulated by the FDA, and distributed by the NIDA, were used following the general techniques utilized by similar studies to help standardize the preparation step. This information has been added to page 3, under the “Preparation of 100% CSEM” methods section.

  • Comment 2: Cell culture treatments need more details, such as if they were serum-deprived (if not, what is the serum concentration?) and what passage was used. Please explain the rationale for using a cancer cell line.

Response: We agree with your suggestion and have incorporated more information regarding the cell culture treatment, passages used, and the rationale behind using the H9 cell lines throughout the manuscript.

  • Comment 3: Please explain the key altered circRNAs and how they are relevant in HIV progression. 

Response: Thank you for your suggestion. It would have been interesting to include this information. However, this is beyond the scope of the current format for this publication as a Data Note, which does not require a Results and Discussion section per F1000Research article guidelines.

  • Comment 4: There are no results and discussion sections; the implications are hard to find.

Response: Thank you for this suggestion. However, our paper was published as a Date Note, which does not require a Results and Discussion section as per F1000Research article guidelines.

We look forward to hearing from you regarding our edits and to respond to any further questions and comments you may have.

Sincerely,

So Jin Hong

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Hong SJ, Russell AE, Witwer KW, et al. : Cigarette Smoke Alters CircRNA Expression in Human T-Cells.[Dataset]. Gene Expression Omnibus. 2023. Reference Source [DOI] [PMC free article] [PubMed]

    Data Availability Statement

    Underlying data

    Gene Expression Omnibus: Cigarette Smoke Alters CircRNA Expression in Human T-Cells. GSE228979; https://identifiers.org/geo/GSE228979 ( Hong et al., 2023).

    This series contains the following underlying data:

    • -

      Datasheet 1 (1.5 Fold Up Regulated circRNAs. Datasheet 1 contains raw and normalized fluorescence intensities from the ArrayStar circRNA Microarray, for 234 circRNAs that were significantly upregulated in H9 cells after cigarette smoke exposure. The circRNA ID was obtained by inputting the transcript and sequence information into circBase or other literatures).

    • -

      Datasheet 2 (1.5 Fold Down Regulated CircRNAs. Datasheet 2 contains raw and normalized fluorescence intensities from the ArrayStar circRNA Microarray, for 42 circRNAs that were significantly downregulated in H9 cells after cigarette smoke exposure. The circRNA ID was obtained by inputting the transcript and sequence information into circBase or PMIDs).


    Articles from F1000Research are provided here courtesy of F1000 Research Ltd

    RESOURCES